NCT07429968

Brief Summary

DSPPea34 (Shared Care Program for Children and Adolescents) is an experimental health program designed to provide rapid, guided care orientation for youth aged 6-18 when a first-line psychological follow-up is considered by a general practitioner or pediatrician. The program links hospital-based services and community providers by offering prompt contact and assessment by a registered nurse and/or psychiatrist, with structured feedback to the referring physician. Primary objective: To identify facilitators that support the engagement of all professionals involved in the care pathway of children and adolescents with psychological difficulties. Facilitators will be mapped across five stages of the pathway: (1) intake, (2) assessment, (3) orientation/referral, (4) inter-partner collaboration, and (5) discharge from the program. Results will be used to refine DSPPea34 specifications to inform broader implementation. Methods and study population (primary objective): A Delphi survey will be conducted with stakeholders directly interacting with families and youth within DSPPea34 (e.g., general practitioners (GP), pediatricians, program clinicians) as well as with program users. Secondary objectives and data sources: To describe (i) the sociodemographic and clinical characteristics of youth using DSPPea34 services and (ii) their care trajectories using quantitative methods. Data will be extracted from DSPPea34 records via the SPICO coordination file (the tool used to facilitate exchanges between the GP/pediatrician, DSPPea34, and the psychologist in charge of follow-up) and complemented by soliciting longitudinal outcome information from the referring physician based on DSPPea34 follow-up. Findings from this mixed-methods evaluation are expected to guide the optimization and potential scale-up of the DSPPea34 model.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
9mo left

Started Mar 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress23%
Mar 2026Mar 2027

First Submitted

Initial submission to the registry

February 3, 2026

Completed
21 days until next milestone

First Posted

Study publicly available on registry

February 24, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

March 1, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

February 24, 2026

Status Verified

February 1, 2026

Enrollment Period

1 year

First QC Date

February 3, 2026

Last Update Submit

February 17, 2026

Conditions

Keywords

Children/adolescentsMental disordersCity-hospital care pathway

Outcome Measures

Primary Outcomes (1)

  • Highlighting by the DELPHI method of the main facilitators of involvement in the DSPPea34 pathway, from successive rounds of proposal prioritization

    These facilitators will be identified at different stages: 1) addressing, 2) evaluation, 3) orientation, 4) collaboration between partners, 5) exit from the device and will allow to evolve the specifications of DSPPea in view of its generalization. Each round includes closed-ended items rated on a 9-point Likert scale (1 = strongly disagree; 9 = strongly agree) assessing both the content and the wording of each proposal. Free-text fields allow participants to provide comments and suggested rewording. Iterative Adaptation Across Rounds: Based on prior-round results, items may be revised, added, or removed. Refinements aim to improve clarity and relevance, while preserving traceability of changes. Consensus Rule (Stopping/Exclusion Criterion for Items): If an item achieves ≥70% agreement (to retain or to remove the proposal) with concordant votes in both Round 1 and Round 2, the proposal is considered

    3 months

Secondary Outcomes (7)

  • Clinical Characterization at Baseline

    At program entry (Baseline)

  • Reason for referral to the program

    Baseline

  • Number of Requests and Referrals (DSPPea34 vs. Outside DSPPea34)

    Baseline

  • Number of Psychiatric Clinical Interviews within DSPPea34

    At program entry (intake) to program completion (from 1 month to 12 months)

  • Number of Joint City-Hospital Follow-Ups

    At program entry (intake) to program completion (from 1 month to 12 months)

  • +2 more secondary outcomes

Study Arms (2)

the professionals directly in contact with families and young people within the framework of DSPPea3

Other: structured online questionnaire

users of the DSPPea34

Other: structured online questionnaireOther: descriptive analysis of patient characteristics and their care pathways, based on electronic medical records

Interventions

A structured, online Delphi survey conducted in up to three iterative rounds to co-develop and refine proposals related to the DSPPea34 specifications. Questionnaires are developed by study facilitators based on the initial DSPPea34 specifications and new proposals arising from the interim evaluation. Content and Response Format: Each round includes closed-ended items rated on a 9-point Likert scale (1 = strongly disagree; 9 = strongly agree) assessing both the content and the wording of each proposal. Free-text fields allow participants to provide comments and suggested rewording. Iterative Adaptation Across Rounds: Based on prior-round results, items may be revised, added, or removed. Refinements aim to improve clarity and relevance, while preserving traceability of changes. Consensus Rule (Stopping/Exclusion Criterion for Items): If an item achieves ≥70% agreement (to retain or to remove the proposal) with concordant votes in both Round 1 and Round 2, the proposal is considered

the professionals directly in contact with families and young people within the framework of DSPPea3users of the DSPPea34

Data collected from all users of the DSPPea34 program since its inception (approximately 1,200 cases) will include: * sociodemographic data (age, gender, living environment (urban, semi-urban, rural) * diagnosis at the end of the initial psychiatric assessment of the DSPPea34 program * referring physician * schooling (grade, mainstream or specialized environment) * existence of previous psychiatric or psychological follow-up * referrals by DSPPea34 staff and reasons (without collection of individual data for young people not included in DSPPea34 at the end of the staff meeting) * referrals at the end of the medical consultation and reasons * end-of-process referrals.

users of the DSPPea34

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

the population of this study (participants responding to the DELPHI questionnaire) includes professionals directly in contact with families and young people within the framework of DSPPea34 as well as users of DSPPea34. * the pediatricians or general practitioners who have referred a child or adolescent to the DSPPea34 * the hospital and private psychiatrist doctors who conducted an initial assessment as part of the DSPPea34 * the city psychologists who are partners of the program having followed at least one child or adolescent within the framework of the DSPPea34 * the Coordination Nurse (IDC) of DSPPea34 * users (legal guardians and young beneficiaries of the care pathway of DSPPea34)

You may qualify if:

  • the professionals directly in contact with families or young people within the framework of DSPPea34 as well as users of DSPPea34

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Montpellier - Réseau DSPPea34 de l'Hérault

Montpellier, Hérault, France

Location

MeSH Terms

Conditions

Mental Disorders

Study Officials

  • Diane PURPER OUAKIL, MD PhD

    CHU de Montpellier

    STUDY DIRECTOR

Central Study Contacts

Diane PURPER OUAKIL, MD PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 3, 2026

First Posted

February 24, 2026

Study Start

March 1, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

March 1, 2027

Last Updated

February 24, 2026

Record last verified: 2026-02

Locations